Vericel Corporation (VCEL): Price and Financial Metrics

Vericel Corporation (VCEL): $47.90

0.82 (-1.68%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add VCEL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#132 of 360

in industry

VCEL Price/Volume Stats

Current price $47.90 52-week high $53.05
Prev. close $48.72 52-week low $29.24
Day low $46.94 Volume 301,400
Day high $48.93 Avg. volume 567,763
50-day MA $47.17 Dividend yield N/A
200-day MA $38.34 Market Cap 2.32B

VCEL Stock Price Chart Interactive Chart >


Vericel Corporation (VCEL) Company Bio


Vericel Corporation focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company was founded in 1989 and is based in Cambridge, Massachusetts.


VCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

VCEL Latest Social Stream


Loading social stream, please wait...

View Full VCEL Social Stream

Latest VCEL News From Around the Web

Below are the latest news stories about VERICEL CORP that investors may wish to consider to help them evaluate VCEL as an investment opportunity.

The five-year returns have been solid for Vericel (NASDAQ:VCEL) shareholders despite underlying losses increasing

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

Yahoo | December 17, 2023

Insider Sell: Director Paul Wotton Offloads 5,000 Shares of Vericel Corp (VCEL)

Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider sell that has caught the attention of investors and market analysts.

Yahoo | December 17, 2023

Insider Sell: President and CEO Dominick Colangelo Sells 24,397 Shares of Vericel Corp (VCEL)

Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider sell by its President and CEO, Dominick Colangelo.

Yahoo | December 9, 2023

Insider Sell: COO Michael Halpin Sells 17,447 Shares of Vericel Corp (VCEL)

Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider transaction.

Yahoo | December 2, 2023

Insider Sell: Chief Medical Officer Jonathan Hopper Sells 5,000 Shares of Vericel Corp (VCEL)

Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently seen a significant insider transaction.

Yahoo | November 23, 2023

Read More 'VCEL' Stories Here

VCEL Price Returns

1-mo 8.22%
3-mo N/A
6-mo 34.29%
1-year 60.58%
3-year -17.39%
5-year 158.64%
YTD 34.51%
2023 35.19%
2022 -32.98%
2021 27.27%
2020 77.47%
2019 0.00%

Continue Researching VCEL

Here are a few links from around the web to help you further your research on Vericel Corp's stock as an investment opportunity:

Vericel Corp (VCEL) Stock Price | Nasdaq
Vericel Corp (VCEL) Stock Quote, History and News - Yahoo Finance
Vericel Corp (VCEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!